Pharmed has sold Accuscience to Diploma PLC
Ireland and UK-based Accuscience has been sold by Pharmed to Diploma PLC.
Accuscience, based in Naas, Ireland, distributes life sciences and medtech equipment. It is a recognized leader in core market segments of the Irish healthcare sector, including clinical diagnostics, blood tracking, resuscitation and mobile/modular healthcare facilities. Through relationships with over 100 suppliers, it delivers a full continuum of value-add services in both Ireland and Northern Ireland, including to the HSE and the NHS.
Diploma is an international group supplying specialized products and services in the life sciences, seals and controls sectors across the UK, Northern Europe, North America and Australia.
Pharmed is a major healthcare and pharmaceutical services provider in Ireland and the UK offering a variety of tailor-made solutions to distribution, sales and marketing for the purpose of representing manufacturers of beauty, pharmaceutical and OTC products. With established global networks, Pharmed provides an extensive range of services to meet the strategic requirements of its partners.
Oaklins’ team in Ireland provided corporate finance advice to Pharmed in this sell-side transaction as well as overall project management services to management and the board. This was a very competitive process with a number of serious bidders from multiple jurisdictions in Europe.
Talk to the deal team
Related deals
The Providence Projects has been acquired by UKAT Group
Celebrity-success rehabilitation center, The Providence Projects, has joined The UK Addiction Treatment (UKAT) Group, backed by Sullivan Street Equity Partners.
Learn moreSt. Claraspital AG has been acquired by University Hospital Basel
University Hospital Basel (USB) has acquired St. Claraspital AG, expanding its network of specialized care and integrated services. With St. Claraspital’s strong community presence, expertise in acute and rehabilitation medicine and established outpatient clinics, this merger enhances USB’s ability to provide seamless, patient-centered treatment across the continuum of care. The completion of the transaction is subject to clearance by the Swiss Competition Commission (COMCO).
Learn moreRAM Infotechnology has acquired Interoperability Group with support from Keensight Capital
RAM Infotechnology (RAM-IT) has acquired Interoperability Group, a leading Dutch provider of healthcare IT solutions, with the support of Keensight Capital, a leading European growth buy-out investor specializing in technology and healthcare.
Learn more